Suchergebnisse - "Criscitiello, C"

PubPharm (47)

21

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Fumagalli, D. | Wilson, T. | Salgado, R. | +19

22

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers

enthalten in: Annals of oncology | 2016

von Fumagalli, D. | Wilson, T. | Salgado, R. | +19

23

Surgery of the primary tumor in de novo metastatic breast cancer : To do or not to do?

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2015

von Criscitiello, C. | Giuliano, M. | Curigliano, G. | +6

24

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer : a retrospective multicenter study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Dieci, M. | Criscitiello, C. | Goubar, A. | +8

ErratumFor: Ann Oncol. 2014 Mar;25(3):611-8. - PMID 24401929

25

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer : recommendations by an International TILs Working Group 2014

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Salgado, R. | Denkert, C. | Demaria, S. | +30

CommentIn: Ann Oncol. 2015 Nov;26(11):2351. - PMID 26347098

26

Immuno-Oncology : 11 tables

Erschienen: Basel, Karger, 2015

Progress in tumor research - 42

von Michielin, O. | Coukos, G.

27

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

enthalten in: Annals of oncology | 2015

von Salgado, R. | Denkert, C. | Demaria, S. | +29

28

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

enthalten in: Annals of oncology | 2015

von Dieci, M. | Criscitiello, C. | Goubar, A. | +8

29

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer : results from the NeoALTTO phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Criscitiello, C. | Azim, H. | de Azambuja, E. | +1

CommentOn: Ann Oncol. 2013 Aug;24(8):1980-5. - PMID 23567146

30

36P * GENE EXPRESSION ANALYSIS OF TRIPLE NEGATIVE RECURRENT LYMPHANGITIC BREAST CANCER IN PATIENTS RECEIVING ANTIANGIOGENIC THERAPY

enthalten in: Annals of oncology | 2014

von Gelao, L. | Bagnardi, V. | Locatelli, M. | +7